Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu. N. Kobzev
Observed names:
Y. Kobzev,
Кобзев Ю.Н.
Institution:
Botkin Hospital
Observed institutions:
Nottingham University Hospitals NHS Trust,
Nottingham City Hospital,
Botkin Hospital,
City Clinical Hospital
ORCID:
0000-0001-7542-9272
Observed ORCID:
0000-0001-7542-9272
OpenAlex ID:
A5062437716
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study
2023
·
O. Yu. Vinogradova
, D. I. Shikhbabaeva
, et al.
·
Oncohematology
·
4
PDF
Azacitidine/Venetoclax Combination as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemias: A First Step
2022
·
M. A. Granatkin
, Evgenii Aleksandrovich Nikitin
, et al.
·
Clinical oncohematology
·
3
Pb2174 Epidemiology of Multiple Myeloma (mm) in Moscow (russia)
2019
·
V. Ptushkin
, O. Vinogradova
, et al.
·
HemaSphere
·
1
Genetic landscape of patients at diagnosis of chronic myeloid leukemia in the chronic phase: association with targeted therapy efficacy
2026
·
O. Yu. Vinogradova
, A. L. Neverova
, et al.
·
Oncohematology
Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience
2023
·
M. A. Granatkin
, E. A. Nikitin
, et al.
·
Oncohematology
PDF
Ps1183 the Potential Impact of Switch to Second Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Chronic Phase Who Had No Optimal Response to 3 Months of Initial Imatinib Therapy
2019
·
O. Vinogradova
, M. Pankrashkina
, et al.
·
HemaSphere
Pf336 Evaluation of Thrombopoietin‐receptor Agonists (tpo‐ras) «stop‐therapy» in Idiopathic Thrombocytopenic Purpura (itp)
2019
·
O. Vinogradova
, M. Pankrashkina
, et al.
·
HemaSphere
Show more works
View as search
Works count:
8
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type
